Curtis J Perry

Publication Activity (10 Years)

Years Active: 2018-2021
Publications (10 Years): 2

Top Topics

Inflammatory Response

Combination Therapy

Basal Cell Carcinoma

Patient Reported Outcomes

Top Venues

The Journal of experimental medicine

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Sarah A Weiss, Dijana Djureinovic, Shlomit Jessel, Irina Krykbaeva, Lin Zhang, Lucia Jilaveanu, Amanda Ralabate, Barbara Johnson, Neta Shanwetter Levit, Gail Anderson, Daniel Zelterman, Wei Wei, Amit Mahajan, Ovid Trifan, Marcus Bosenberg, Susan M Kaech, Curtis J Perry, William E Damsky, Scott Gettinger, Mario Sznol, Michael Hurwitz, Harriet M Kluger
A Phase I Study of APX005M and Cabiralizumab with or without Nivolumab in Patients with Melanoma, Kidney Cancer, or Non-Small Cell Lung Cancer Resistant to Anti-PD-1/PD-L1. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (17) (2021)
Curtis J Perry, Andrés R Muñoz-Rojas, Katrina M Meeth, Laura N Kellman, Robert A Amezquita, Durga Thakral, Victor Y Du, Jake Xiao Wang, William Damsky, Alexandra L Kuhlmann, Joel W Sher, Marcus Bosenberg, Kathryn Miller-Jensen, Susan M Kaech
Myeloid-targeted immunotherapies act in synergy to induce inflammation and antitumor immunity. The Journal of experimental medicine 215 (3) (2018)